Rh and Kell phenotyping in voluntary blood donors: A study from a tertiary care blood center of western India.

Introduction: In human beings, there are 45 blood group systems and 360 antigens currently recognized by ISBT (July 2023). The Rh blood group system has 56 antigens, out of them 5 antigens D, C, c, E, and e are clinically significant antigens. The Kell blood group system has 25 highly immunogenic antigens.

Combining sentiment analysis classifiers to explore multilingual news articles covering London 2012 and Rio 2016 Olympics.

This study aims to present an approach for the challenges of working with Sentiment Analysis (SA) applied to news articles in a multilingual corpus. It looks at the use and combination of multiple algorithms to explore news articles published in English and Portuguese. It presents a methodology that starts by evaluating and combining four SA algorithms (SenticNet, SentiStrength, Vader and BERT, being BERT trained in two datasets) to improve the quality of outputs.

A machine learning-based approach to determine infection status in recipients of BBV152 (Covaxin) whole-virion inactivated SARS-CoV-2 vaccine for serological surveys.

Data science has been an invaluable part of the COVID-19 pandemic response with multiple applications, ranging from tracking viral evolution to understanding the vaccine effectiveness. Asymptomatic breakthrough infections have been a major problem in assessing vaccine effectiveness in populations globally. Serological discrimination of vaccine response from infection has so far been limited to Spike protein vaccines since whole virion vaccines generate antibodies against all the viral proteins.

Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2.

To understand the spread of SARS-CoV2, in August and September 2020, the Council of Scientific and Industrial Research (India) conducted a serosurvey across its constituent laboratories and centers across India. Of 10,427 volunteers, 1058 (10.14%) tested positive for SARS-CoV2 anti-nucleocapsid (anti-NC) antibodies, 95% of which had surrogate neutralization activity.